Alpha Tau Medical logo

Alpha Tau MedicalNASDAQ: DRTS

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

Israel

IPO:

08 March 2021

Next earnings report:

15 November 2024

Last dividends:

N/A

Next dividends:

N/A
$159.70 M
-84%vs. 3y high
50%vs. sector
-vs. 3y high
-vs. sector
-74%vs. 3y high
59%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | 17 min ago
$2.28+$0.01(+0.61%)

Dividend

No data over the past 3 years

Analysts recommendations

Institutional Ownership

DRTS Latest News

Alpha Tau Announces Acceptance Into FDA's Total Product Life Cycle Advisory Program to Accelerate Market Access to Alpha DaRT® for Patients with Recurrent Glioblastoma Multiforme
globenewswire.com21 October 2024 Sentiment: POSITIVE

JERUSALEM, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-emitters cancer therapy Alpha DaRT®, announced today that it has been accepted into the prestigious Total Product Life Cycle (TPLC) Advisory Program (“TAP”) Pilot of the U.S. Food and Drug Administration (“FDA”), to accelerate market access to the Alpha DaRT for patients with recurrent glioblastoma multiforme (“GBM”). This acceptance follows the Company's previous receipt of Breakthrough Device Designation from the FDA for this indication, one of two such designations received for the Alpha DaRT, and a pre-requisite for application to the TAP program.

Alpha Tau Treats First Patient with Recurrent Lung Cancer
globenewswire.com10 October 2024 Sentiment: POSITIVE

JERUSALEM, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that its first patient with recurrent lung cancer has been treated, in a clinical trial at Hadassah Medical Center in Jerusalem, Israel.

Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC
globenewswire.com20 September 2024 Sentiment: POSITIVE

-Trial to focus on particularly vulnerable subset of patients, following strong clinician interest in use of the Alpha DaRT in this patient population - -Trial to focus on particularly vulnerable subset of patients, following strong clinician interest in use of the Alpha DaRT in this patient population -

Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit
GlobeNewsWire25 March 2024 Sentiment: POSITIVE

JERUSALEM, March 25, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that CFO Raphi Levy will present a corporate overview and update at the Jefferies Radiopharma Innovation Summit on April 11th, 2024.

Is Alpha Tau Medical (DRTS) Stock Outpacing Its Medical Peers This Year?
Zacks Investment Research22 January 2024 Sentiment: POSITIVE

Here is how Alpha Tau Medical Ltd. (DRTS) and Regeneron (REGN) have performed compared to their sector so far this year.

Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewsWire20 December 2023 Sentiment: POSITIVE

- The overview presentation will review some of the Company's recent achievements, including highly promising interim results from the Company's pancreatic cancer safety and feasibility trial as well as robust long-term data analyzed across four clinical trials -

Down -20.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Alpha Tau Medical Ltd. (DRTS)
Zacks Investment Research22 November 2023 Sentiment: POSITIVE

Alpha Tau Medical Ltd. (DRTS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it.

Alpha Tau Medical to Participate in June Investor Conferences
GlobeNewsWire24 May 2023 Sentiment: NEUTRAL

JERUSALEM, May 24, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that management will participate in the following investor conferences.

Should You Buy Alpha Tau Medical (DRTS) Ahead of Earnings?
Zacks Investment Research22 May 2023 Sentiment: POSITIVE

Alpha Tau Medical (DRTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day
GlobeNewsWire03 May 2023 Sentiment: POSITIVE

JERUSALEM, May 03, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that Raphi Levy, Chief Financial Officer, will take part in a fireside chat at the Guggenheim Radiopharmaceuticals Day in New York City on Monday, May 15th, 2023.

What type of business is Alpha Tau Medical?

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

What sector is Alpha Tau Medical in?

Alpha Tau Medical is in the Healthcare sector

What industry is Alpha Tau Medical in?

Alpha Tau Medical is in the Biotechnology industry

What country is Alpha Tau Medical from?

Alpha Tau Medical is headquartered in Israel

When did Alpha Tau Medical go public?

Alpha Tau Medical initial public offering (IPO) was on 08 March 2021

What is Alpha Tau Medical website?

https://www.alphatau.com

Is Alpha Tau Medical in the S&P 500?

No, Alpha Tau Medical is not included in the S&P 500 index

Is Alpha Tau Medical in the NASDAQ 100?

No, Alpha Tau Medical is not included in the NASDAQ 100 index

Is Alpha Tau Medical in the Dow Jones?

No, Alpha Tau Medical is not included in the Dow Jones index

When was Alpha Tau Medical the previous earnings report?

No data

When does Alpha Tau Medical earnings report?

The next expected earnings date for Alpha Tau Medical is 15 November 2024